The E&C Committee held a hearing July 18, 2017, with witnesses from the Office of Pharmacy Affairs, the Government Accountability Office and the Office of Inspector General. The committee asked pertinent questions administered under oath to the following individuals regarding the 340B program and oversight:
Recent Posts
340B Corner: Energy & Commerce Committee Hearing “Examining HRSA’s Oversight of the 340B Drug Pricing Program” Part 1
Posted by Brennan Newell on Jul 21, 2017 10:22:49 AM
0 Comments Click here to read/write comments
Topics: 340B, 340b compliance